ZA200701281B - Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors - Google Patents

Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors

Info

Publication number: ZA200701281B
Authority: ZA; South Africa
Prior art keywords: pyrazole; protein kinase; kinase inhibitors; aminoheteroaryl compounds; substituted aminoheteroaryl
Prior art date: 2004-08-26

Application number

ZA200701281A

Other languages

English (en)

Inventor

Cui Jingrong Jean

Jia Lei

Meng Jerry Jialun

Pairist Mason Alan

Tran-Dube Michelle Bich

Funk Lee Andrew

Kung Pei-Pei

Nambu Mitchell David

Shen Hong

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-26

Filing date

2007-02-13

Publication date

2008-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35677463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200701281(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-02-13 Application filed by Pfizer filed Critical Pfizer

2008-12-31 Publication of ZA200701281B publication Critical patent/ZA200701281B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Pyridine Compounds (AREA)

ZA200701281A 2004-08-26 2007-02-13 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors ZA200701281B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US60524404P	2004-08-26	2004-08-26
US69080305P	2005-06-14	2005-06-14

Publications (1)

Publication Number	Publication Date
ZA200701281B true ZA200701281B (en)	2008-12-31

Family

ID=35677463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200701281A ZA200701281B (en)	2004-08-26	2007-02-13	Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors

Country Status (43)

Country	Link
US (1)	US20060128724A1 (xx)
EP (1)	EP1784396B8 (xx)
JP (1)	JP4167295B2 (xx)
KR (1)	KR100869393B1 (xx)
CN (1)	CN101018780B (xx)
AP (1)	AP2332A (xx)
AR (1)	AR050529A1 (xx)
AT (1)	ATE492544T1 (xx)
AU (1)	AU2005276132B2 (xx)
BR (1)	BRPI0514537B8 (xx)
CA (1)	CA2577937C (xx)
CR (2)	CR8938A (xx)
CY (1)	CY1111138T1 (xx)
DE (1)	DE602005025499D1 (xx)
DK (1)	DK1784396T3 (xx)
EA (1)	EA011725B1 (xx)
EC (1)	ECSP077278A (xx)
ES (1)	ES2355923T3 (xx)
GE (1)	GEP20094845B (xx)
GT (1)	GT200500226A (xx)
HN (1)	HN2005000477A (xx)
HR (1)	HRP20110116T1 (xx)
IL (1)	IL181045A0 (xx)
MA (1)	MA28827B1 (xx)
ME (1)	ME01309B (xx)
MX (1)	MX2007002310A (xx)
MY (1)	MY139942A (xx)
NI (1)	NI200700058A (xx)
NL (1)	NL1029809C2 (xx)
NO (1)	NO338656B1 (xx)
NZ (1)	NZ552946A (xx)
PA (1)	PA8643201A1 (xx)
PE (1)	PE20060651A1 (xx)
PL (1)	PL1784396T3 (xx)
PT (1)	PT1784396E (xx)
RS (1)	RS51601B (xx)
SI (1)	SI1784396T1 (xx)
SV (1)	SV2006002208A (xx)
TN (1)	TNSN07071A1 (xx)
TW (1)	TWI300411B (xx)
UY (1)	UY29080A1 (xx)
WO (1)	WO2006021881A2 (xx)
ZA (1)	ZA200701281B (xx)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2476667T3 (da) *	2003-02-26	2014-09-15	Sugen Inc	Aminoheteroaryl-forbindelser som proteinkinase-inhibitorer
MX2007002312A (es)	2004-08-26	2007-04-16	Pfizer	Compuestos de aminoheteroarilo enantiomericamente puros como inhibidores de proteina quinasa.
US20070072908A1 (en) *	2005-06-08	2007-03-29	Japan Tobacco Inc.	Heterocyclic compounds
PT1963302E (pt) *	2005-12-05	2013-04-09	Pfizer Prod Inc	Polimorfos de um inibidor de c-met/hgfr
PL1959955T3 (pl) *	2005-12-05	2011-04-29	Pfizer Prod Inc	Sposób traktowania nieprawidłowego wzrostu komórek
WO2008051808A2 (en)	2006-10-23	2008-05-02	Sgx Pharmaceuticals, Inc.	Bicyclic triazoles as protein kinase modulators
GB0621607D0 (en) *	2006-10-31	2006-12-06	Chroma Therapeutics Ltd	Inhibitors of c-Met
MY148851A (en)	2006-12-14	2013-06-14	Bayer Ip Gmbh	Dihydropyridine derivatives as useful as protein kinase inhibitors
US8551995B2 (en) *	2007-01-19	2013-10-08	Xcovery Holding Company, Llc	Kinase inhibitor compounds
CA2683559C (en) *	2007-04-13	2019-09-24	Dana Farber Cancer Institute, Inc.	Methods for treating cancer resistant to erbb therapeutics
US8263585B2 (en)	2007-05-04	2012-09-11	Novartis Ag	Organic compounds
DE102007026341A1 (de)	2007-06-06	2008-12-11	Merck Patent Gmbh	Benzoxazolonderivate
JP5973131B2 (ja)	2007-09-13	2016-08-23	コデクシス，インコーポレイテッド	アセトフェノンの還元のためのケトレダクターゼポリペプチド
AU2008315746A1 (en)	2007-10-25	2009-04-30	Astrazeneca Ab	Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
JP2011511005A (ja)	2008-02-04	2011-04-07	オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド	２−アミノピリジン系キナーゼ阻害薬
AR070317A1 (es)	2008-02-06	2010-03-31	Osi Pharm Inc	Furo (3,2-c) piridina y tieno (3,2-c) piridinas
US8268834B2 (en) *	2008-03-19	2012-09-18	Novartis Ag	Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
KR20100134693A (ko)	2008-04-23	2010-12-23	교와 핫꼬 기린 가부시키가이샤	2-아미노퀴나졸린 유도체
KR101034351B1 (ko) *	2008-05-14	2011-05-16	한국화학연구원	신규 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의약학적으로 허용가능한 염, 이의 제조방법 및 이를유효성분으로 함유하는 이상세포 성장 질환의 예방 및치료용 약학적 조성물
NZ590542A (en)	2008-06-19	2012-12-21	Xcovery Holding Co Llc	Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
JP2012509342A (ja) *	2008-11-20	2012-04-19	オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド	置換ピロロ［２，３−ｂ］−ピリジンおよび−ピラジン
DE102009003975A1 (de)	2009-01-07	2010-07-08	Merck Patent Gmbh	Benzothiazolonderivate
AU2010254053A1 (en) *	2009-05-28	2011-12-01	Vertex Pharmaceuticals Incorporated	Substituted pyrazole inhibitors of c-Met protein kinase
EP2451802A1 (en)	2009-07-07	2012-05-16	Pathway Therapeutics, Inc.	Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
DE102009056886A1 (de)	2009-12-03	2011-06-09	Bayer Schering Pharma Aktiengesellschaft	cMet-Inhibitoren zur Behandlung der Endometriose
WO2011100502A1 (en) *	2010-02-11	2011-08-18	OSI Pharmaceuticals, LLC	7-aminofuropyridine derivatives
EA201290822A1 (ru) *	2010-02-22	2013-03-29	ГЛЭКСОСМИТКЛАЙН ЭлЭлСи	Триазолоны в качестве ингибиторов синтазы жирных кислот
WO2011109593A1 (en)	2010-03-03	2011-09-09	OSI Pharmaceuticals, LLC	Substituted-5-aminopyrrolo/pyrazolopyridines
EP2566858A2 (en) *	2010-05-04	2013-03-13	Pfizer Inc.	Heterocyclic derivatives as alk inhibitors
US8513238B2 (en) *	2010-05-10	2013-08-20	Hoffmann-La Roche Inc.	Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
WO2011143646A1 (en)	2010-05-14	2011-11-17	OSI Pharmaceuticals, LLC	Fused bicyclic kinase inhibitors
AR081039A1 (es)	2010-05-14	2012-05-30	Osi Pharmaceuticals Llc	Inhibidores biciclicos fusionados de quinasa
EA201690998A1 (ru)	2010-05-17	2017-01-30	Инкозен Терапьютикс Пвт. Лтд.	НОВЫЕ СОЕДИНЕНИЯ 3,5-ДИЗАМЕЩЕННОГО-3H-ИМИДАЗО[4,5-b]ПИРИДИНА И 3,5-ДИЗАМЕЩЕННОГО-3H-[1,2,3]ТРИАЗОЛО[4,5-b]ПИРИДИНА КАК МОДУЛЯТОРЫ ПРОТЕИНКИНАЗ
CN101857594B (zh) *	2010-06-18	2013-04-03	南方医科大学	一种四氢吡啶并吲哚类化合物及其制备方法和应用
US20130315895A1 (en)	2010-07-01	2013-11-28	Takeda Pharmaceutical Company Limited	COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
WO2012003544A1 (en) *	2010-07-09	2012-01-12	The Walter And Eliza Hall Institute Of Medical Research	Protein kinase inhibitors and methods of treatment
CN101967140A (zh) *	2010-09-14	2011-02-09	郑州泰基鸿诺药物科技有限公司	氘代克里唑蒂尼及其衍生物、制备方法和应用
BR112013008523B1 (pt)	2010-10-08	2021-12-07	Xcovery Holdings, Inc	Compostos de piridazina carboxamida substituídos e usos dos mesmos para tratar câncer, uma doença de proliferação, uma doença neurológica, uma doença psiquiátrica, obesidade, diabetes ou doença cardiovascular
US9145390B2 (en)	2011-03-03	2015-09-29	Concert Pharmaceuticals, Inc.	Derivatives of pyrazole-substituted amino-heteroaryl compounds
ES2608967T3 (es)	2011-03-28	2017-04-17	Mei Pharma, Inc.	(Aralquilamino sustituido en alfa y heteroarilalquilamino)pirimidinil y 1,3,5-triazinil benzimidazoles, composiciones farmacéuticas que los contienen, y estos compuestos para usar en el tratamiento de enfermedades proliferativas
JP2014513724A (ja)	2011-05-16	2014-06-05	オーエスアイ・ファーマシューティカルズ，エルエルシー	融合二環キナーゼ阻害剤
CN102850328B (zh) *	2011-07-01	2014-12-24	苏州东南药业股份有限公司	吡啶类化合物、其制备方法、包含该化合物的药物组合物及其用途
EP2739617A4 (en) *	2011-07-27	2015-01-28	Nanjing Allgen Pharma Co Ltd	SPIROCYCLIC MOLECULES AS PROTEIN KINASE INHIBITORS
BR112014002141A2 (pt)	2011-08-02	2017-02-21	Pfizer	crizotinib para uso no tratamento de câncer
WO2013041038A1 (en) *	2011-09-21	2013-03-28	Teligene Ltd.	Pyridine compounds as inhibitors of kinase
CN103087050A (zh) *	2011-10-28	2013-05-08	山东轩竹医药科技有限公司	芳基激酶抑制剂
CA2863892C (en)	2012-03-06	2016-08-30	Pfizer Inc.	Macrocyclic derivatives for the treatment of proliferative diseases
CN103304552B (zh) *	2012-03-09	2016-12-28	广东东阳光药业有限公司	取代的吡啶化合物及其使用方法和用途
WO2013138210A1 (en) *	2012-03-14	2013-09-19	Ning Xi	Substituted cyclic compounds and methods of use
HK1207072A1 (en)	2012-03-16	2016-01-22	埃克希金医药品有限公司	3,5-diaminopyrazole kinase inhibitors
CN103319468B (zh) *	2012-03-21	2016-07-13	广东东阳光药业有限公司	取代的螺双环化合物及其使用方法和用途
WO2013144191A1 (de)	2012-03-29	2013-10-03	Bayer Intellectual Property Gmbh	Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen
EA026412B1 (ru)	2012-03-30	2017-04-28	Ризен Фармасьютикалз Са	НОВЫЕ СОЕДИНЕНИЯ 3,5-ДИЗАМЕЩЕННОГО-3H-ИМИДАЗО[4,5-b]ПИРИДИНА И 3,5-ДИЗАМЕЩЕННОГО-3H-[1,2,3]ТРИАЗОЛО[4,5-b]ПИРИДИНА КАК МОДУЛЯТОРЫ c-MET ПРОТЕИНКИНАЗ
WO2013152252A1 (en)	2012-04-06	2013-10-10	OSI Pharmaceuticals, LLC	Combination anti-cancer therapy
CN106349222B (zh) *	2012-04-22	2019-03-05	东南大学	克里唑替尼前药及其制备方法与用途
KR101582852B1 (ko)	2012-05-24	2016-01-07	서울대학교 산학협력단	타우 단백질 매개 신경 퇴행성 질환 치료제
WO2013181251A1 (en)	2012-05-29	2013-12-05	Ratiopharm Gmbh	Crizotinib hydrochloride salt in crystalline
GB201211310D0 (en) *	2012-06-26	2012-08-08	Chroma Therapeutics Ltd	CSF-1R kinase inhibitors
WO2014020467A2 (en)	2012-07-30	2014-02-06	Fresenius Kabi Oncology Ltd	Process for the preparation of pyrazole substituted aminoheteroaryl compounds
JO3215B1 (ar)	2012-08-09	2018-03-08	Phenex Pharmaceuticals Ag	حلقات غير متجانسة بها 5 ذرات تحتوي على النيتروجين بها استبدال بكربوكساميد أو سلفوناميد كمعدلات لمستقبل نووي غير محمي RORy
AU2013307383A1 (en) *	2012-08-27	2015-03-26	Cemm - Forschungszentrum Fur Molekulare Medizin Gmbh	Aminoheteroaryl compounds as MTH1 inhibitors
CN103720691A (zh) *	2012-10-11	2014-04-16	韩冰	一类治疗脑性瘫痪的化合物及其用途
WO2014060381A1 (de)	2012-10-18	2014-04-24	Bayer Cropscience Ag	Heterocyclische verbindungen als schädlingsbekämpfungsmittel
WO2014081816A1 (en) *	2012-11-21	2014-05-30	Concert Pharmaceuticals, Inc.	Fluoro-derivatives of pyrazole-substituted amino-heteroaryl compounds
EP2945938B1 (en)	2013-01-18	2018-03-07	F. Hoffmann-La Roche AG	3-substituted pyrazoles and use as dlk inhibitors
AU2014211856C1 (en) *	2013-02-02	2018-04-12	Centaurus Biopharma Co., Ltd.	Substituted 2-aminopyridine protein kinase inhibitor
CN103992307B (zh) *	2013-02-16	2017-07-14	浙江九洲药物科技有限公司	一种克里唑替尼的制备方法
WO2014139391A1 (en) *	2013-03-11	2014-09-18	Teligene Ltd	Substituted pyridine compounds as kinases inhibitors
US9765035B2 (en)	2013-03-14	2017-09-19	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
CA2903264A1 (en)	2013-03-14	2014-11-06	Epizyme, Inc.	Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
EP2970181B1 (en)	2013-03-14	2017-06-07	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
US9120757B2 (en)	2013-03-14	2015-09-01	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
EP2970135B1 (en)	2013-03-14	2018-07-18	Epizyme, Inc.	Pyrazole derivatives as prmt1 inhibitors and uses thereof
US9133189B2 (en)	2013-03-14	2015-09-15	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
US9447079B2 (en)	2013-03-14	2016-09-20	Epizyme, Inc.	PRMT1 inhibitors and uses thereof
MX382991B (es)	2013-03-14	2025-03-13	Epizyme Inc	Inhibidores de la arginina metiltransferasa y usos de los mismos.
EP2970131B1 (en)	2013-03-14	2017-11-15	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
CN104059054B (zh) *	2013-03-19	2018-11-20	浙江导明医药科技有限公司	用于治疗癌症的三级环状胺alk激酶抑制剂
WO2014203177A1 (en) *	2013-06-18	2014-12-24	Shilpa Medicare Limited	Amorphous (r) -3- [1- (2, 6-dichloro-3-fluorophenyl) methoxy] -5- [1- (piperidin-4- yl) -1h-pyrazol-4-yl] pyridin-2-amine
CN104230890A (zh) *	2013-06-19	2014-12-24	信诺凯（北京）化工有限公司	吡啶-2-胺衍生物及其制法和药物组合物与用途
CN104650049B (zh) *	2013-08-28	2018-06-08	广东东阳光药业有限公司	取代的吡啶化合物及其使用方法和用途
KR101598664B1 (ko)	2013-09-04	2016-03-02	씨제이헬스케어 주식회사	피롤로피리다진 유도체를 포함하는 단백질 키나제 억제제
WO2015034729A1 (en) *	2013-09-05	2015-03-12	Calitor Sciences, Llc	Substituted pyridine compounds and methods of use
NZ631142A (en)	2013-09-18	2016-03-31	Axikin Pharmaceuticals Inc	Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
WO2015046653A1 (ko)	2013-09-30	2015-04-02	한국화학연구원	신규한 트리아졸로 피라진 유도체 및 그의 용도
CA2943329A1 (en)	2014-03-24	2015-10-01	Genentech, Inc.	Cancer treatment with c-met antagonists and correlation of the latter with hgf expression
WO2015172747A1 (en) *	2014-05-16	2015-11-19	Zhaoyin Wang	Spirocyclic molecules as mth1 inhibitors
JP2017530950A (ja)	2014-08-25	2017-10-19	ファイザー・インコーポレイテッド	癌を処置するためのｐｄ−１アンタゴニストおよびａｌｋ阻害剤の併用
WO2016044576A1 (en) *	2014-09-17	2016-03-24	Epizyme, Inc.	Salts, co-crystals, amorphous forms, and crystalline forms of an arginine methyltransferase inhibitor
CN104402868B (zh) *	2014-11-04	2016-08-24	郑州泰基鸿诺医药股份有限公司	氘代克里唑蒂尼晶型及其制备方法
ES2764299T3 (es)	2014-12-09	2020-06-02	Inst Nat Sante Rech Med	Anticuerpos monoclonales humanos contra AXL
EA032473B1 (ru)	2014-12-23	2019-05-31	Аксикин Фармасьютикалз, Инк.	3,5-диаминопиразоловые ингибиторы киназы
WO2016135041A1 (en)	2015-02-26	2016-09-01	INSERM (Institut National de la Santé et de la Recherche Médicale)	Fusion proteins and antibodies comprising thereof for promoting apoptosis
WO2016145383A1 (en) *	2015-03-11	2016-09-15	Board Of Regents, University Of Texas System	Mth1 inhibitors for treating disease
JP6966423B2 (ja)	2015-04-24	2021-11-17	グアンジョウマキシノベルファーマシューティカルズカンパニーリミテッド	縮合環ピリミジンアミノ誘導体、その製造方法、中間体、薬学的組成物及び応用
CN106279112A (zh) *	2015-06-12	2017-01-04	浙江九洲药业股份有限公司	一种克里唑替尼中间体及其制备方法和应用
CA3000386A1 (en)	2015-09-30	2017-04-06	Merck Patent Gmbh	Combination of a pd-1 axis binding antagonist and an alk inhibitor for treating alk-negative cancer
EP4019019B1 (en)	2016-05-20	2024-02-07	Biohaven Pharmaceutical Holding Company Ltd.	Use of riluzole, riluzole prodrugs or riluzole analogs with immunotherapies to treat cancers
TWI646094B (zh) *	2016-06-01	2019-01-01	大陸商貝達藥業股份有限公司	Crystal form of inhibitory protein kinase active compound and application thereof
CN106632260B (zh) *	2016-09-29	2019-04-26	上海天慈生物谷生物工程有限公司	一种小分子激酶抑制剂的制备方法
CN117860758A (zh)	2017-05-23	2024-04-12	梅制药公司	联合疗法
US11351176B2 (en)	2017-08-14	2022-06-07	Mei Pharma, Inc.	Combination therapy
CN110372664A (zh) *	2018-04-13	2019-10-25	华东理工大学	选择性jak2抑制剂及其应用
KR102207608B1 (ko)	2019-04-24	2021-01-26	윤종오	카르복실산으로 유기화된 규소 이온 복합체 및 복합체의 제조방법과 이를 이용한 제품
CN115745979B (zh) *	2021-11-11	2025-09-23	中国医学科学院医药生物技术研究所	一种蛋白靶向降解化合物及其用途
CN119451699A (zh)	2022-07-04	2025-02-14	中外制药株式会社	并用药物
EP4582104A1 (en)	2022-08-30	2025-07-09	Chugai Seiyaku Kabushiki Kaisha	Combination drug

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI941572L (fi) *	1991-10-07	1994-05-27	Oncologix Inc	Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
DE69334255D1 (de) *	1992-02-06	2009-02-12	Novartis Vaccines & Diagnostic	Marker für Krebs und biosynthetisches Bindeprotein dafür
US5863949A (en) *	1995-03-08	1999-01-26	Pfizer Inc	Arylsulfonylamino hydroxamic acid derivatives
PT821671E (pt) *	1995-04-20	2001-04-30	Pfizer	Derivados do acido arilsulfonil hidroxamico como inibidores de mmp e tnf
US5747498A (en) *	1996-05-28	1998-05-05	Pfizer Inc.	Alkynyl and azido-substituted 4-anilinoquinazolines
US5880141A (en) *	1995-06-07	1999-03-09	Sugen, Inc.	Benzylidene-Z-indoline compounds for the treatment of disease
GB9518953D0 (en) *	1995-09-15	1995-11-15	Pfizer Ltd	Pharmaceutical formulations
CA2259222A1 (en) *	1996-06-27	1997-12-31	Pfizer Inc.	Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors
JPH11236333A (ja) *	1997-12-30	1999-08-31	Pfizer Prod Inc	抗ガン剤として有用なイミダゾリン−４−オン誘導体
ATE321037T1 (de) *	1998-08-27	2006-04-15	Pfizer Prod Inc	Als antikrebsmittel verwendbare alkinyl- substituierte chinolin-2-on-derivate
ES2237125T3 (es) *	1998-08-27	2005-07-16	Pfizer Products Inc.	Derivados de quinolin-2-ona utiles como agentes anticancerigenos.
EP1006113A1 (en) *	1998-12-02	2000-06-07	Pfizer Products Inc.	Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth
US6682736B1 (en) *	1998-12-23	2004-01-27	Abgenix, Inc.	Human monoclonal antibodies to CTLA-4
JP3270834B2 (ja) *	1999-01-27	2002-04-02	ファイザー・プロダクツ・インク	抗がん剤として有用なヘテロ芳香族二環式誘導体
UA71945C2 (en) *	1999-01-27	2005-01-17	Pfizer Prod Inc	Substituted bicyclic derivatives being used as anticancer agents
ES2243228T3 (es) *	1999-02-11	2005-12-01	Pfizer Products Inc.	Derivados quinolin-2-ona sustituidos con heteroarilo utiles como agentes anticancerigenos.
US6586447B1 (en) *	1999-04-01	2003-07-01	Pfizer Inc	3,3-disubstituted-oxindole derivatives useful as anticancer agents
EP1081137A1 (en) *	1999-08-12	2001-03-07	Pfizer Products Inc.	Selective inhibitors of aggrecanase in osteoarthritis treatment
PT1106612E (pt) *	1999-11-30	2004-06-30	Pfizer Prod Inc	Derivados de quinolina uteis para inibir a farnesil-proteina-transferase
HN2000000266A (es) *	2000-01-21	2001-05-21	Pfizer Prod Inc	Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
US6844357B2 (en) *	2000-05-01	2005-01-18	Pfizer Inc.	Substituted quinolin-2-one derivatives useful as antiproliferative agents
SE0102438D0 (sv) *	2001-07-05	2001-07-05	Astrazeneca Ab	New compounds
SE0102439D0 (sv) *	2001-07-05	2001-07-05	Astrazeneca Ab	New compounds
AU2003206109A1 (en) *	2002-02-06	2003-09-02	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Catechol bioisosteres
AU2003246927A1 (en) *	2002-07-03	2004-01-23	Astex Technology Limited	3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
WO2004013091A2 (en) *	2002-08-01	2004-02-12	Yissum Research Development Company Of The Hebrew University Of Jerusalem	4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases
SE0203754D0 (sv) *	2002-12-17	2002-12-17	Astrazeneca Ab	New compounds
DE10307845A1 (de) *	2003-02-25	2004-09-02	Bayer Cropscience Gmbh	Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
DK2476667T3 (da) *	2003-02-26	2014-09-15	Sugen Inc	Aminoheteroaryl-forbindelser som proteinkinase-inhibitorer
MX2007002312A (es) *	2004-08-26	2007-04-16	Pfizer	Compuestos de aminoheteroarilo enantiomericamente puros como inhibidores de proteina quinasa.

2005
- 2005-08-15 SI SI200531231T patent/SI1784396T1/sl unknown
- 2005-08-15 DK DK05782821.2T patent/DK1784396T3/da active
- 2005-08-15 EA EA200700321A patent/EA011725B1/ru active Protection Beyond IP Right Term
- 2005-08-15 KR KR1020077004564A patent/KR100869393B1/ko not_active Expired - Lifetime
- 2005-08-15 WO PCT/IB2005/002695 patent/WO2006021881A2/en not_active Ceased
- 2005-08-15 DE DE602005025499T patent/DE602005025499D1/de not_active Expired - Lifetime
- 2005-08-15 ME MEP-2011-40A patent/ME01309B/me unknown
- 2005-08-15 BR BRPI0514537A patent/BRPI0514537B8/pt active IP Right Grant
- 2005-08-15 GE GEAP20059888A patent/GEP20094845B/en unknown
- 2005-08-15 ES ES05782821T patent/ES2355923T3/es not_active Expired - Lifetime
- 2005-08-15 AP AP2007003906A patent/AP2332A/xx active
- 2005-08-15 AU AU2005276132A patent/AU2005276132B2/en active Active
- 2005-08-15 HR HR20110116T patent/HRP20110116T1/hr unknown
- 2005-08-15 JP JP2007529029A patent/JP4167295B2/ja not_active Expired - Lifetime
- 2005-08-15 EP EP05782821A patent/EP1784396B8/en not_active Expired - Lifetime
- 2005-08-15 CA CA2577937A patent/CA2577937C/en not_active Expired - Lifetime
- 2005-08-15 PL PL05782821T patent/PL1784396T3/pl unknown
- 2005-08-15 PT PT05782821T patent/PT1784396E/pt unknown
- 2005-08-15 CN CN200580030636XA patent/CN101018780B/zh not_active Expired - Lifetime
- 2005-08-15 RS RS20110085A patent/RS51601B/sr unknown
- 2005-08-15 AT AT05782821T patent/ATE492544T1/de active
- 2005-08-15 MX MX2007002310A patent/MX2007002310A/es active IP Right Grant
- 2005-08-15 NZ NZ552946A patent/NZ552946A/en not_active IP Right Cessation
- 2005-08-19 MY MYPI20053921A patent/MY139942A/en unknown
- 2005-08-23 AR ARP050103534A patent/AR050529A1/es active IP Right Grant
- 2005-08-23 UY UY29080A patent/UY29080A1/es active IP Right Grant
- 2005-08-24 HN HN2005000477A patent/HN2005000477A/es unknown
- 2005-08-24 GT GT200500226A patent/GT200500226A/es unknown
- 2005-08-24 PE PE2005000974A patent/PE20060651A1/es active IP Right Grant
- 2005-08-25 TW TW094129028A patent/TWI300411B/zh not_active IP Right Cessation
- 2005-08-25 NL NL1029809A patent/NL1029809C2/nl not_active IP Right Cessation
- 2005-08-26 SV SV2005002208A patent/SV2006002208A/es unknown
- 2005-08-26 US US11/213,039 patent/US20060128724A1/en not_active Abandoned
- 2005-08-26 PA PA20058643201A patent/PA8643201A1/es unknown
2007
- 2007-01-29 IL IL181045A patent/IL181045A0/en unknown
- 2007-02-13 ZA ZA200701281A patent/ZA200701281B/xx unknown
- 2007-02-21 CR CR8938A patent/CR8938A/es unknown
- 2007-02-23 TN TNP2007000071A patent/TNSN07071A1/fr unknown
- 2007-02-23 NI NI200700058A patent/NI200700058A/es unknown
- 2007-02-26 MA MA29719A patent/MA28827B1/fr unknown
- 2007-02-26 EC EC2007007278A patent/ECSP077278A/es unknown
- 2007-03-09 NO NO20071320A patent/NO338656B1/no unknown
2011
- 2011-01-27 CY CY20111100092T patent/CY1111138T1/el unknown
2012
- 2012-08-10 CR CR20120421A patent/CR20120421A/es unknown

Also Published As

Publication number	Publication date
PA8643201A1 (es)	2006-06-02
SI1784396T1 (sl)	2011-03-31
WO2006021881A3 (en)	2006-05-18
PT1784396E (pt)	2011-01-27
CR20120421A (es)	2012-09-14
GEP20094845B (en)	2009-11-25
TW200621751A (en)	2006-07-01
HRP20110116T1 (hr)	2011-03-31
DK1784396T3 (da)	2011-02-14
AP2007003906A0 (en)	2007-02-28
PE20060651A1 (es)	2006-07-19
TWI300411B (en)	2008-09-01
JP2008510788A (ja)	2008-04-10
NZ552946A (en)	2010-09-30
WO2006021881A2 (en)	2006-03-02
ATE492544T1 (de)	2011-01-15
NL1029809C2 (nl)	2006-10-17
GT200500226A (es)	2006-04-10
NL1029809A1 (nl)	2006-02-28
MA28827B1 (fr)	2007-08-01
US20060128724A1 (en)	2006-06-15
CN101018780B (zh)	2012-01-11
CA2577937A1 (en)	2006-03-02
RS51601B (sr)	2011-08-31
CA2577937C (en)	2010-12-21
EP1784396A2 (en)	2007-05-16
IL181045A0 (en)	2007-07-04
EP1784396B1 (en)	2010-12-22
HN2005000477A (es)	2010-06-09
NO20071320L (no)	2007-05-29
CR8938A (es)	2007-08-14
BRPI0514537B8 (pt)	2021-05-25
KR100869393B1 (ko)	2008-11-21
AP2332A (en)	2011-12-05
ES2355923T3 (es)	2011-04-01
BRPI0514537A (pt)	2008-06-17
AU2005276132B2 (en)	2011-09-29
AU2005276132A1 (en)	2006-03-02
ME01309B (me)	2013-12-20
JP4167295B2 (ja)	2008-10-15
HK1105415A1 (en)	2008-04-03
EA011725B1 (ru)	2009-04-28
MX2007002310A (es)	2007-05-08
BRPI0514537B1 (pt)	2020-05-12
EP1784396B8 (en)	2011-04-20
AR050529A1 (es)	2006-11-01
NO338656B1 (no)	2016-09-26
KR20070038569A (ko)	2007-04-10
TNSN07071A1 (fr)	2008-06-02
DE602005025499D1 (de)	2011-02-03
SV2006002208A (es)	2006-10-04
NI200700058A (es)	2008-03-07
UY29080A1 (es)	2006-03-31
ECSP077278A (es)	2007-03-29
EA200700321A1 (ru)	2007-08-31
MY139942A (en)	2009-11-30
PL1784396T3 (pl)	2011-05-31
CN101018780A (zh)	2007-08-15
CY1111138T1 (el)	2015-06-11

Publication	Publication Date	Title
IL181045A0 (en)	2007-07-04	Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
AP2114A (en)	2010-03-04	Aminoheteroaryl compounds as protein kinase inhibitors
IL181384A0 (en)	2007-07-04	Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
IL177278A0 (en)	2006-12-10	Pyrazolotriazines as kinase inhibitors
IL179613A0 (en)	2007-05-15	Compounds and compositions as protein kinase inhibitors
PL1713806T3 (pl)	2013-09-30	Związki i kompozycje jako inhibitory kinaz białkowych
IL182687A0 (en)	2007-09-20	Compounds and compositions as protein kinase inhibitors
PL1891066T3 (pl)	2011-05-31	Związki i kompozycje jako inhibitory kinazy białkowej
EP1841431A4 (en)	2009-12-09	COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
EP1794137A4 (en)	2009-12-02	SPECIFIC KINASE INHIBITORS
IL177283A0 (en)	2006-12-10	Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
ZA200709269B (en)	2009-01-28	Protein kinase inhibitors
IL183276A0 (en)	2007-10-31	Kinase inhibitors
EP1778693A4 (en)	2009-11-11	AS KINASEINHIBITORS USEFUL COMPOUNDS OF TRICYCLIC HETEROARYL
ZA200607648B (en)	2008-06-25	Kinase inhibitors
EP1765820A4 (en)	2010-07-21	COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF PROTEIN KINASES
SI2476667T1 (sl)	2014-10-30	Aminoheteroarilne spojine kot inhibitorji protein-kinaze
ZA200703130B (en)	2008-07-30	Compounds and compositions as protein kinase inhibitors
ZA200810573B (en)	2009-09-30	Substituted 3-cyanopyridines as protein kinase inhibitors
HK1108892A (en)	2008-05-23	Protein kinase inhibitors
HK1090927A (en)	2007-01-05	Pyrazolotriazines as kinase inhibitors
EP1940411A4 (en)	2008-10-29	MACROHETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS